[Skip to Navigation]
Sign In
Figure 1. 
Influenza vaccination coverage in the United States for individuals 65 years or older, by age group.

Influenza vaccination coverage in the United States for individuals 65 years or older, by age group.18

Figure 2. 
Influenza vaccination coverage in the United States for individuals 65 years or older, by race and ethnicity.

Influenza vaccination coverage in the United States for individuals 65 years or older, by race and ethnicity.18,23

Table 1. 
Multivariable Logistic Regression Analysis of the Effect of Selected Indicators on Influenza Vaccination of 5757 Elderly Adults, 2002
Multivariable Logistic Regression Analysis of the Effect of Selected Indicators on Influenza Vaccination of 5757 Elderly Adults, 200218
Table 2. 
Percentage of Elderly Individuals in the United States Who Reported Receiving Influenza Vaccine in the Past 12 Months, by Demographic Characteristics, 1989-2002
Percentage of Elderly Individuals in the United States Who Reported Receiving Influenza Vaccine in the Past 12 Months, by Demographic Characteristics, 1989-200218
Table 3. 
Percentage of Individuals 65 Years or Older in the United States Who Reported Receiving Influenza Vaccine in the Past 12 Months, by Health Care Access Characteristics, 1989-2002
Percentage of Individuals 65 Years or Older in the United States Who Reported Receiving Influenza Vaccine in the Past 12 Months, by Health Care Access Characteristics, 1989-200218
1.
Harper  SAFukuda  KUyeki  TMCox  NJBridges  CBCenters for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53:743].  MMWR Recomm Rep 2004;53 ((RR-6)) 1- 40PubMedGoogle Scholar
2.
Poland  GACouch  R Intranasal influenza vaccine: adding to the armamentarium for influenza control.  JAMA 1999;282182- 184PubMedGoogle ScholarCrossref
3.
Thompson  WWShay  DKWeintraub  E  et al.  Influenza-associated hospitalizations in the United States.  JAMA 2004;2921333- 1340PubMedGoogle ScholarCrossref
4.
Thompson  WWShay  DKWeintraub  E  et al.  Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA 2003;289179- 186PubMedGoogle ScholarCrossref
5.
Simonsen  LClarke  MJSchonberger  LBArden  NHCox  NJFukuda  K Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.  J Infect Dis 1998;17853- 60PubMedGoogle ScholarCrossref
6.
Fedson  DSWajda  ANicol  PJHammond  GWKaiser  DLRoos  LL Clinical effectiveness of influenza vaccination in Manitoba.  JAMA 1993;2701956- 1961PubMedGoogle ScholarCrossref
7.
Nichol  KLMargolis  KLWuorenma  JVon Sternberg  T The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.  N Engl J Med 1994;331778- 784PubMedGoogle ScholarCrossref
8.
McBean  AMBabish  JDWarren  JL The impact and cost of influenza in the elderly.  Arch Intern Med 1993;1532105- 2111PubMedGoogle ScholarCrossref
9.
Gross  PAHermogenes  AWSachs  HSLau  JLevandowski  RA The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature.  Ann Intern Med 1995;123518- 527PubMedGoogle ScholarCrossref
10.
Vu  TFarish  SJenkins  MKelly  H A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.  Vaccine 2002;201831- 1836PubMedGoogle ScholarCrossref
11.
Fedson  DSHouck  PBratzler  D Hospital-based influenza and pneumococcal vaccination: Sutton’s law applied to prevention.  Infect Control Hosp Epidemiol 2000;21692- 699PubMedGoogle ScholarCrossref
12.
Govaert  TMEThijs  CTMasurel  NSprenger  MJDinant  GJKnottnerus  JA The efficacy of influenza vaccination in the elderly individuals: a randomized double-blind placebo-controlled trial.  JAMA 1994;2721661- 1665PubMedGoogle ScholarCrossref
13.
Fedson  DS Adult immunization: summary of the National Vaccine Advisory Committee Report.  JAMA 1994;2721133- 1137PubMedGoogle ScholarCrossref
14.
Nichol  KL Ten-year durability and success of an organized program to increase influenza an pneumococcal vaccination rates among high-risk adults.  Am J Med 1998;105385- 392PubMedGoogle ScholarCrossref
15.
Centers for Disease Control and Prevention (CDC), Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep 1997;46 ((RR-9)) 1- 25Google Scholar
16.
Public Health Service, Healthy People 2000: National Health Promotion and Disease Prevention Objectives: Healthy People 2000 Review 1998-1999.  Washington, DC US Dept of Health and Human Services, Public Health Services1999;DHHS publication (PHS)99-1256
17.
US Department of Health and Human Services, Healthy People 2010. Conference ed. Washington, DC US Dept of Health and Human Services;2000;
18.
Centers for Disease Control and Prevention (CDC), National Health Interview Survey. Available at: http://www.cdc.gov/nchs/about/major/nhis/quest_data_related_doc.htm. Accessed March 10, 2004
19.
National Center for Health Statistics, Vital and Health Statistics: Design and Estimation for National Health Interview Survey, 1985-1994.  Hyattsville, Md National Center for Health Statistics1989;DHHS publication 89-1384
20.
National Center for Health Statistics, Vital and Health Statistics: Design and Estimation for National Health Interview Survey 1995-2004.  Hyattsville, Md National Center for Health Statistics2000;DHHS publication 2000-1330
21.
U.S. Census Bureau, Current poverty data. Available at: http://www.census.gov/hhes/www/poverty/poverty.html. Accessed May 8, 2004
22.
Shah  BBarnwell  BBieier  G SUDAAN User’s Manual, Release 7.5.  Research Triangle Park, NC Research Triangle Institute1997;
23.
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics.  National Health Interview Survey, 1989-1991 [data sets on CD ROM]. Series 10. Atlanta, Ga Centers for Disease Control and Prevention1993;Google Scholar
24.
 Influenza and pneumococcal vaccination levels among persons aged ≥65 years–United States, 1973-1993.  MMWR Morb Mortal Wkly Rep 1995;44506- 507, 513-515PubMedGoogle Scholar
25.
Centers for Disease Control and Prevention (CDC), Estimated influenza vaccination coverage among adults and children—United States, September 1, 2004–January 31, 2005.  MMWR Morb Mortal Wkly Rep 2005;54304- 307PubMedGoogle Scholar
26.
Singleton  JAPoel  AJLu  PJNichol  KLIwane  MK Where adults reported receiving influenza vaccination in the United States  Am J Infect Control In pressGoogle Scholar
27.
Davis  MMMcMahon  SRSantoli  JMSchwartz  BClark  SJ A national survey of physician practices regarding influenza vaccine.  J Gen Intern Med 2002;17670- 676PubMedGoogle ScholarCrossref
28.
Casalino  LGillies  RRShortell  SM  et al.  External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases.  JAMA 2003;289434- 441PubMedGoogle ScholarCrossref
29.
Shefer  ABriss  PRodewald  L  et al.  Improving immunization coverage rates: an evidence-based review of the literature.  Epidemiol Rev 1999;2196- 142PubMedGoogle ScholarCrossref
30.
Stone  EGMorton  SCHulscher  ME  et al.  Interventions that increase use of adult immunization and cancer screening services: a meta-analysis.  Ann Intern Med 2002;136641- 651PubMedGoogle ScholarCrossref
31.
Coleman  MSFontanesi  JMeltzer  MI  et al.  Estimating medical practice expenses from administering adult influenza vaccinations.  Vaccine 2005;23915- 923Google ScholarCrossref
32.
Centers for Medicare and Medicaid Services, Medicare Preventive Services: Flu Pneus. Available at: http://www.cms.hhs.gov/preventiveservices/2l.pdf. Accessed January 20, 2005
33.
Centers for Medicare and Medicaid Services, Medicare Preventive Service: Influenza/Pneumococcal Campaign. Available at: http://www.cms.hhs.gov/preventiveservices/2.asp. Accessed January 20, 2005
34.
Nichol  KLMacDonald  RHauge  M Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.  J Gen Intern Med 1996;11673- 677PubMedGoogle ScholarCrossref
35.
 Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations–United States, 1996.  MMWR Morb Mortal Wkly Rep 1999;48886- 890PubMedGoogle Scholar
36.
Zimmerman  RKSantibanez  TAJanosky  JE  et al.  What affects influenza vaccination rates among older patients? an analysis from inner-city, suburban, rural, and Veterans Affairs practices.  Am J Med 2003;11431- 38PubMedGoogle ScholarCrossref
37.
Nicoleau  ANicoleau  CABalzora  JDOboh  ASiddiqui  NRosenberg  C Elderly African-Americans and the influenza vaccine: the impact of the primary care physician.  J Am Med Dir Assoc 2001;256- 59PubMedGoogle ScholarCrossref
38.
Horby  PWWilliams  ABurgess  MAWang  H Prevalence and determinants of influenza vaccination in Australians aged 40 years and over: a national survey.  Aust N Z J Public Health 2005;2935- 37PubMedGoogle ScholarCrossref
39.
Nunes  BContreiras  TFalcao  JM Influenza vaccination: coverage of Portuguese population from 1998/1999 to 2002/2003 [in Portuguese] [published correction appears in Rev Port Pneumol. 2004;10:451-452].  Rev Port Pneumol 2004;10115- 123PubMedGoogle Scholar
40.
Jin  YCarriere  KCPredy  GJohnson  DHMarrie  TJ The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta.  Can J Public Health 2003;94341- 345PubMedGoogle Scholar
41.
Luthi  JCMean  FAmmon  CBurnand  B Evaluation of a population-based prevention program against influenza among Swiss elderly people.  Swiss Med Wkly 2002;132592- 597Google Scholar
42.
Singleton  JAGreby  SMWooten  KGWalker  FJStrikas  R Influenza, pneumococcal, and tetanus toxoid vaccination of adults–United States, 1993-7.  MMWR CDC Surveill Summ 2000;4939- 62PubMedGoogle Scholar
43.
Singleton  JALu  PJ Influenza vaccination levels in the United States, 1998 [abstract].  Abstracts of the 35th National Immunization Conference. Atlanta, Ga;2001;
44.
 Race-specific differences in influenza vaccination levels among Medicare beneficiaries–United States, 1993.  MMWR Morb Mortal Wkly Rep 1995;4424- 27, 33PubMedGoogle Scholar
45.
Bach  PBPham  HHSchrag  DTate  RCHargraves  JL Primary care physicians who treat blacks and whites.  N Engl J Med 2004;351575- 584PubMedGoogle ScholarCrossref
46.
Schneider  ECZaslavsky  AMEpstein  AM Racial disparities in the quality of care for enrollees in Medicare managed care.  JAMA 2002;2871288- 1294PubMedGoogle ScholarCrossref
47.
Gemson  DHElinson  JMesseri  P Differences in physician prevention practice patterns for white and minority patients.  J Community Health 1988;1353- 64PubMedGoogle ScholarCrossref
48.
 Influenza and pneumococcal vaccination levels among persons aged ≥65 years–United States, 1999.  MMWR Morb Mortal Wkly Rep 2001;50532- 537PubMedGoogle Scholar
49.
Petersen  RLSaag  KWallace  RBDoebbeling  BN Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study.  Med Care 1999;37502- 509PubMedGoogle ScholarCrossref
50.
Lave  JRIves  DGTraven  NDKuller  LH Participation in health promotion programs by the rural elderly.  Am J Prev Med 1995;1146- 53PubMedGoogle Scholar
51.
Mac Donald  RBaken  LNelson  ANichol  KL Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.  Am J Prev Med 1999;16173- 177PubMedGoogle ScholarCrossref
52.
Nichol  KLKorn  JEBaum  P Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire.  Am J Prev Med 1991;7199- 203PubMedGoogle Scholar
53.
Hutchison  BG Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost.  Can J Public Health 1989;80271- 275PubMedGoogle Scholar
54.
 Centers for Disease Control and Prevention (CDC).  Interim estimates of populations targeted for influenza vaccination from 2003 National Health Interview Survey data and estimates for 2004 based on influenza vaccine shortage priority groups. Available at: http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf. Accessed November 10, 2004Google Scholar
55.
Centers for Disease Control and Prevention (CDC), Public health and aging: influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years—United States, 2002.  MMWR Morb Mortal Wkly Rep 2003;52987- 992PubMedGoogle Scholar
Original Investigation
September 12, 2005

Influenza Vaccination Trends Among Adults 65 Years or Older in the United States, 1989-2002

Author Affiliations

Author Affiliations: Epidemiology and Surveillance Division, National Immunization Program (Drs Lu and Bridges and Mr Singleton), Division of HIV/AIDS Prevention–Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention (Dr Rangel), and Immunization Service Division, National Immunization Program (Dr Wortley), Centers for Disease Control and Prevention, Atlanta, Ga.

Arch Intern Med. 2005;165(16):1849-1856. doi:10.1001/archinte.165.16.1849
Abstract

Background  Influenza vaccination of elderly individuals (65 years or older) has been recommended in the United States since 1961, and consistent surveillance of vaccine use has been conducted since 1989. We examined national trends in influenza vaccination coverage in the United States from 1989 to 2002 among noninstitutionalized elderly individuals and identified factors associated with receipt of influenza vaccine.

Methods  We analyzed data from the 1989-2002 National Health Interview Surveys, weighted to reflect the civilian, noninstitutionalized US population to determine self-reported levels of influenza vaccination. We conducted multivariable logistic regression modeling of 2002 data to identify factors independently associated with self-reported influenza vaccination.

Results  Among the elderly, influenza vaccination coverage increased from 30.5% in 1989 to 65.6% in 2002, with only a 2.4% increase from 1997 to 2002. In 2002, coverage remained lower for the non-Hispanic black (49.6%) and Hispanic (48.5%) populations compared with non-Hispanic whites (68.6%). Characteristics associated with a lower likelihood of influenza vaccination included fewer than 4 physician contacts in the past year and whether a person (1) was divorced or separated, (2) was non-Hispanic black or Hispanic, (3) had no regular physician, and (4) had less than a high school education. Individuals with chronic medical conditions and those 75 years or older were more likely to be vaccinated.

Conclusions  By 1997, influenza vaccination coverage exceeded the Healthy People 2000 objective of 60% for the elderly overall, but even by 2002, this objective was still not achieved in the elderly black and Hispanic populations. Vaccination coverage seems to be leveling off, and innovative initiatives are needed to reach the Healthy People 2010 target of 90%, especially among racial and ethnic minorities.

Influenza causes significant morbidity and mortality in adults. Illnesses caused by influenza occur in an average of 5% to 20% of the US population annually.1 About 50% of those who become ill seek medical care, 1% of those who seek medical care are hospitalized, and 8% of those who are hospitalized die as a consequence of influenza.2 Overall, on average, each year approximately 226 000 patients are hospitalized for influenza-related respiratory or circulatory illnesses,3 and approximately 36 000 individuals die of influenza-associated causes, more than 90% of whom are elderly (65 years or older).4,5

Vaccination significantly reduces influenza-related morbidity and mortality in adults. In the elderly population, the influenza vaccine is 50% to 60% effective in preventing hospitalization and 80% effective in preventing death resulting from pneumonia and influenza.6-12 The US Public Health Service has recommended influenza vaccination of elderly and chronically ill individuals since 1961, and Medicare coverage for influenza vaccination began in 1993. However, despite the presence of a safe and effective vaccine, long-standing recommendations to vaccinate all elderly individuals, and federal financial support for vaccination of the elderly population, vaccination levels are not optimal.13-15

Healthy People 200016 objectives included increasing vaccination levels to at least 60% in the noninstitutionalized elderly population. Healthy People 201017 objectives call for raising influenza vaccination coverage in that group to 90%.

This article describes national trends in influenza vaccination coverage in the United States from 1989 to 2002 in the noninstitutionalized elderly population, assesses progress toward Healthy People 2010 health objectives, and identifies factors associated with receipt of influenza vaccine.

Methods

The National Health Interview Survey (NHIS)18 is a multistage cluster survey that has been conducted annually in the United States by the National Center for Health Statistics since 1957. The NHIS provides estimates on health indicators, health care utilization and access, and health-related behaviors for the US-resident civilian noninstitutionalized population (ie, individuals in nursing homes or prisons are not included in the survey population). The results are weighted to reflect the US-resident civilian noninstitutionalized population. Interviews are conducted weekly throughout the year with a probability sample of households during face-to-face interviews. Data collected over the period of a year form the basis for annual estimates of the health characteristics of the US population and trends in these characteristics. The NHIS questionnaire consists of 2 main parts: (1) a set of basic health and demographic items and (2) 1 or more sets of questions about current health topics. The basic items constitute approximately 50% of the questionnaire and are repeated each year. Questions on current health topics facilitate a response to changing needs for data and cover a wide variety of issues.19,20

The 1989 immunization supplement, the 1991 health promotion and disease prevention supplement, the 1993 and 1995 surveys on Healthy People 2000 objectives, and the 1997-2002 sample adult core surveys included questions about adult immunizations.18 The questions regarding influenza and pneumococcal vaccination were as follows: “During the past 12 months, have you had a flu shot?” and “Have you ever had a pneumonia shot?” respectively. We used data from the 1989, 1991, 1993, 1995, and 1997-2002 NHIS for the trend analysis. We limited the study population for this analysis to elderly respondents. Unweighted sample sizes of 14 245, 8123, 4047, 3442, 6745, 6257, 6002, 6091, 6046, and 5757 elderly respondents were analyzed for the 1989, 1991, 1993, 1995, 1997, 1998, 1999, 2000, 2001, and 2002 surveys, respectively. We excluded respondents who did not know their influenza vaccination status (0.8%) from the analysis.

To further assess ongoing vaccination efforts, we stratified influenza vaccination levels for all years by age group (65-74, 75-84, and 85 years or older), race and ethnicity, marital status, level of education, NHIS poverty index, employment status, number of physician contacts in the previous year, interval in years since the last visit to a physician, whether a person had been hospitalized in the past year, whether a person has a regular physician, and whether the individual had health insurance. The NHIS poverty index is based on family size, number of children younger than 18 years, and family income using the poverty levels from the year prior to the survey derived from the US Census Bureau.21

We used SAS (SAS Inc, Cary, NC) and SUDAAN (Research Triangle Institute, Research Triangle Park, NC) statistical software to calculate point estimates and 95% confidence intervals for each year.22 We weighted all analyses to reflect the age, sex, and race and ethnicity of the US-resident civilian noninstitutionalized population. To determine predictors for influenza vaccination in the elderly population, we analyzed the 2002 NHIS data. Multivariable logistic regression models were performed using backward elimination and forward selection of variables. Variables were initially included in the full model if the Wald χ2P values were less than .10 in individual bivariate logistic models. We individually removed potential variables that added least to the component model, and we reestimated a new model until only variables significantly associated with the outcome (P<.05) remained. We calculated standardized odds ratio estimates from the logistic regression model. The odds ratio may overestimate the relative risk as a result of common outcome. The order of independent variables given in Table 1 is based on the significance of Wald χ2 statistical tests. To evaluate missed opportunities for influenza vaccination in the elderly population, we calculated the percentage of individuals with selected health care characteristics from among those who did not report receipt of influenza vaccine in the past 12 months.

Results

In the elderly population, influenza vaccination coverage increased from 30.5% (95% confidence interval [CI], 29.4%-31.6%) in 1989 to 65.6% (95% CI, 64.1%-67.1%) in 2002, with a 2.7% average annual increase (Table 2). In all years, adults 75 years or older were significantly more likely to report vaccination than those aged 65 to 74 years (Table 2 and Figure 1). Vaccination rates in the non-Hispanic white population have been significantly higher than in other racial and ethnic groups, except in 1993 when Hispanics had rates similar to those of whites. The average annual percentage point increase from 1989 to 2002 was also higher for whites than for other racial and ethnic groups (2.8% for whites, 2.4% for blacks, and 1.8% for Hispanics, respectively), with flattening of the increase for all groups combined (annual average change, 0.65%) during 2000 to 2002 (Figure 2).

Coverage levels during 2002 were higher among persons at or above the poverty level compared with those living below the poverty level (66.9% vs 51.0%). Each year, there was a significant upward trend in reported vaccination levels with increasing educational level (Table 2).

Marital status also was associated with receipt of influenza vaccination. In all years from 1989 to 2002, elderly individuals who were currently married had significantly higher vaccination rates than those not married or alone. Those in the elderly population who were divorced or separated had the lowest vaccine coverage. In 2002, the influenza vaccination coverage for the elderly who were married was 69.1% (95% CI, 67.0%-71.2%) compared with 47.9% (95% CI, 44.0%-51.8%) for the elderly who were divorced or separated (Table 2).

There was a 40% difference in influenza vaccination coverage between those who had a regular place of care and those who did not have one in 2002 (67.0% vs 27.9%). Elderly individuals who had seen a physician in the past year were also more likely to report having received the influenza vaccine (68.2%; 95% CI, 66.7%-69.7%) than those who had not (31.8%; 95% CI, 26.5%-37.1%) (Table 3).

In all years, those in the elderly population who had been hospitalized in the past year were significantly more likely to report receipt of influenza vaccine than those who were not hospitalized in the past year. In addition, in each year, the rate of influenza vaccination increased as the number of physician contacts increased. In 2002, there was almost a 37 percentage point difference in vaccination levels between those who had not visited a physician and those who had had 10 or more physician contacts in the past year (Table 3).

We conducted multivariate logistic regression analysis of the 2002 NHIS data set18 to identify independent factors for influenza vaccination in the elderly population. Influenza vaccination was independently associated with the number of visits to physicians in the past year, marital status, age, race and ethnicity, chronic medical conditions, having a regular place for care, and educational level (Table 1).

Among those who reported not obtaining an influenza vaccine in the preceding year, 97.6% had health insurance, 92.3% had a regular place for care, 84.1% had had 1 or more physician contacts, 15.1% had 10 or more physician contacts in the past year, 15.1% were hospitalized within the past year, 20.3% had visited an emergency department, and 22.9% had received the pneumococcal vaccine. Thus, even unvaccinated individuals had had frequent contact with the medical system (data not shown).

Comment

The NHIS data from 1989-2002 showed that influenza vaccine coverage in the US elderly population had steadily increased from 1989 to 1997 but leveled off after 1997. The Healthy People 2000 goal of 60% coverage for noninstitutionalized elderly individuals was met in 1997 overall. However, although whites met the goal in 1995, the 2002 vaccination rates for other racial and ethnic groups remained below the 2000 goal. Attainment of the Healthy People 2010 goal of 90% for all racial and ethnic groups poses a formidable challenge. The marked slowing in the influenza vaccination coverage increase that began after 1997 is a matter of substantial concern and suggests that new approaches are needed if increases in influenza vaccination are to occur.

Several factors have influenced influenza vaccination uptake over time. First, vaccination recommendations have changed over time. Beginning in 1961, the US Public Health Service specifically recommended annual influenza vaccination for all individuals 65 years or older or at least 6 months old with certain chronic medical conditions, but between 1962 and 1987, elderly persons with chronic medical conditions were intermittently given higher priority for vaccination than those without a recognized high-risk condition. Between 1973 and 1985, US influenza vaccination rates in the elderly, based on the US Immunization Survey, ranged from 22% to 30% except during the 1976-1977 swine flu vaccine campaign, when 38% of the elderly population were vaccinated.24 Since 1988, elderly individuals with or without chronic conditions have been given equal priority for influenza vaccination, and since 1989 the NHIS has included a question on influenza vaccination. From 1989 to 1997, a steady increase in vaccination coverage was noted with the change to an age-based recommendation.

Second, since 1993 Medicare has paid for influenza vaccine, removing financial barriers to vaccination for Medicare beneficiaries. Although vaccination rates did not increase markedly in the first year after implementation of Medicare coverage, they continued to gradually increase.

Third, the supply and timing of the availability of influenza vaccine have been unpredictable in recent years. In 2000, a substantial delay in influenza vaccine availability and distribution followed by a less severe delay in 2001 likely contributed to the recent lack of progress in improving vaccination coverage, although slowing of the increase in coverage began before 2000. However, the relative contribution of all of these factors to vaccination coverage is unclear.

Regardless, ensuring a reliable supply of influenza vaccine is essential if vaccination coverage is to increase. The limited supply of inactivated influenza vaccine during the severe shortage in 2004-2005 was largely successfully prioritized to the high-risk population, including the elderly, and preliminary estimates suggest that coverage in this group was comparable to that of recent years.25 Comparison with the 2005 NHIS data (available in 2006) will be needed to further assess the overall impact of this shortage on vaccine coverage in high-risk groups. However, progress toward to the 2010 Healthy People goal of 90% coverage will not be attainable if there continues to be an unreliable supply of influenza vaccine.

Reasons for the leveling-off of coverage rates since 1997 are not well understood. Most of the elderly who are vaccinated receive their influenza vaccination in a clinical setting (physician’s office, 58%; health clinic, 12%).26 One reason for the leveling-off of coverage rates in recent years may be that the number of elderly who are able or willing to make the effort to seek vaccination in clinical settings has reached its limit given the current low level of interventions in place to promote immunization.27,28 Effective approaches for increasing vaccination have been well documented,29 and among the most effective interventions are systems changes that are designed to make the identification and delivery of preventive services routine, such as standing-order programs or special immunization clinics.30 Promoting the implementation of interventions to increase vaccination rates is not straightforward because that implementation requires additional effort and incentives for health care providers. In addition, it has been shown31 that providing influenza vaccinations can result in financial loss to health care providers, in smaller clinical settings in particular, potentially constituting a business-based disincentive to provide immunizations. This remains true even after Medicare’s 2003 doubling of the physician administration fee.32 However, in January 2005, the Medicare reimbursement rate for vaccine administration was substantially boosted from approximately $8 to approximately $18, an increase that may encourage physicians' interest in providing vaccinations.33 The unreliable supply of influenza vaccine in recent years may also discourage physicians from offering influenza vaccine in their clinics in the future, and this trend needs to be monitored. An increase in providing vaccination in alternative settings (community immunization programs, health department clinics, pharmacies, etc) may be part of the solution; however, patients must be motivated to seek out vaccination, and a physician’s recommendation remains one of the most important determinants of vaccination.34

Concerns about the adverse effects of vaccination, lack of awareness of the need for vaccination, and perceived lack of effectiveness are cited as leading reasons for nonvaccination.35,36 In a survey conducted during January 2005 (Centers for Disease Control and Prevention, unpublished data, 2005) among unvaccinated individuals, the main reasons cited for nonvaccination included concerns about adverse effects (16%), the opinion that the vaccine is not needed (30%), lack of knowledge of a recommendation for influenza vaccine (4%), and lack of a recommendation by a physician (2%).

Although surveys34 show that individuals with concerns about the vaccine who receive a physician recommendation are more likely to be vaccinated than those who do not receive a physician recommendation, a prospective study37 among elderly African Americans has shown that most patients who had not been vaccinated because of concerns about the vaccine remained unvaccinated even after a strong physician recommendation, in marked contrast to those who had not been vaccinated because of lack of awareness or lack of a strong enough recommendation. If the 90% goal is to be reached, substantial efforts are needed to educate the public about the true risk of adverse effects of the vaccine, the risk of severe illness from influenza even for healthy elderly individuals, and the benefits of vaccination. Studies in other industrialized countries have found similar concerns among unvaccinated individuals and vaccination rates that are generally below 80% among the elderly, including 78% in Australia in 2001,38 37% in Portugal in 2003,39 70% in Alberta, Canada, in 2000,40 and 58% in Switzerland in 2000.41

Racial and ethnic disparities reported in other surveys42-44 were confirmed in our analysis. Our analysis and others42-44 show that these disparities persist after taking into account sociodemographic factors and access to care. Among Medicare beneficiaries, a 20-percentage-point gap exists between black and white beneficiaries, whether they are enrolled in Medicare-managed care or in a fee-for-service plan. These differences are not well understood and may result from a combination of factors, including differences in the quality of care accessed by other racial and ethnic groups compared with the white population,45-47 differences in attitudes toward vaccination and toward preventive care in general, and differences in physician-patient interactions. Findings from the Medicare Current Beneficiary Survey35 show no marked differences in reasons for nonvaccination by race and ethnicity. Concerns about vaccination may be more prevalent among blacks and Hispanics given that the unvaccinated account for a greater proportion of these groups.

Education levels were independently associated with self-reported receipt of influenza vaccine. Elderly individuals with an education beyond high school were more likely to receive the vaccine than those with less education. Our findings are consistent with previous surveys. The elderly who did not complete high school may experience more barriers to receiving care because they lack knowledge about preventive services.48-50 Our study also found that married elderly individuals were more likely to be vaccinated than those divorced or alone. Based on other studies, married couples are more frequent users of preventive services because of the improved social supports, easier transportation, and greater likelihood of having previously established a regular source of health care. Systems to improve the ease of access to vaccination services of those without social support networks are needed and may help improve coverage levels.

Physician contact and recommendation for vaccination services can be a strong determinant of a patient’s decision to be vaccinated,34,42 but such contacts with the medical system do not guarantee vaccination. Our multivariable logistic model shows that physician contacts within the preceding year and having chronic medical conditions were independently associated with influenza vaccine coverage. However, a substantial proportion of the elderly who had visited their physician at least 10 times or had been hospitalized still did not get vaccinated. Furthermore, 15% of unvaccinated individuals had been hospitalized within the past year, a group likely to be at highest risk of influenza complications. Use of standing-order programs can help reduce the number of missed opportunities for vaccination of individuals who have already accessed the medical system and should be instituted in all health care settings, including inpatient and outpatient settings.

A limitation of our study is that information on influenza vaccination was determined only by self-report and was not verified by medical records. Memory bias may exist. However, previous studies51-53 have found that self-report of influenza vaccination by adults was sensitive and specific for influenza vaccination compared with review of medical records. In addition, high-risk medical conditions are also self-reported, and some conditions associated with increased risk of influenza complications are not included in the NHIS.

The number of individuals vaccinated against influenza in the United States each year is remarkable: approximately 70 to 75 million in 2002 for all age groups.54 Given the potential reductions in deaths and hospitalizations, the goal is to vaccinate at least 90% of the elderly. The elderly are particularly important given that the most severe outcomes occur at much higher rates in individuals 65 years or older. Therefore, the lack of continuing increases in vaccination rates should cause concern and indicates that new approaches are needed. Priorities include better understanding of how to add a routine offering of vaccinations, including ensuring vaccination for patients who access the medical system for other reasons; addressing concerns about the risk of influenza and the risks and benefits of vaccination; developing and implementing effective approaches to increasing vaccination among racial and ethnic groups with low coverage; and devising ways to provide immunizations in additional alternative, convenient settings for those unable or unwilling to seek out vaccination in more traditional settings. Finally, a wide disparity exists in health care coverage among states.55 A closer examination of the health care environment and synergies between different groups, including the Center for Medicare and Medicaid Services Quality Improvement Organizations, public health adult immunization programs, and community immunization programs in states with high coverage rates may yield clues to help improve vaccination coverage.

Correspondence: Peng-Jun Lu, PhD, MPH, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E-61, Atlanta, GA 30333 (plu@cdc.gov).

Accepted for Publication: May 5, 2005.

Financial Disclosure: None.

References
1.
Harper  SAFukuda  KUyeki  TMCox  NJBridges  CBCenters for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53:743].  MMWR Recomm Rep 2004;53 ((RR-6)) 1- 40PubMedGoogle Scholar
2.
Poland  GACouch  R Intranasal influenza vaccine: adding to the armamentarium for influenza control.  JAMA 1999;282182- 184PubMedGoogle ScholarCrossref
3.
Thompson  WWShay  DKWeintraub  E  et al.  Influenza-associated hospitalizations in the United States.  JAMA 2004;2921333- 1340PubMedGoogle ScholarCrossref
4.
Thompson  WWShay  DKWeintraub  E  et al.  Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA 2003;289179- 186PubMedGoogle ScholarCrossref
5.
Simonsen  LClarke  MJSchonberger  LBArden  NHCox  NJFukuda  K Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.  J Infect Dis 1998;17853- 60PubMedGoogle ScholarCrossref
6.
Fedson  DSWajda  ANicol  PJHammond  GWKaiser  DLRoos  LL Clinical effectiveness of influenza vaccination in Manitoba.  JAMA 1993;2701956- 1961PubMedGoogle ScholarCrossref
7.
Nichol  KLMargolis  KLWuorenma  JVon Sternberg  T The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.  N Engl J Med 1994;331778- 784PubMedGoogle ScholarCrossref
8.
McBean  AMBabish  JDWarren  JL The impact and cost of influenza in the elderly.  Arch Intern Med 1993;1532105- 2111PubMedGoogle ScholarCrossref
9.
Gross  PAHermogenes  AWSachs  HSLau  JLevandowski  RA The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature.  Ann Intern Med 1995;123518- 527PubMedGoogle ScholarCrossref
10.
Vu  TFarish  SJenkins  MKelly  H A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.  Vaccine 2002;201831- 1836PubMedGoogle ScholarCrossref
11.
Fedson  DSHouck  PBratzler  D Hospital-based influenza and pneumococcal vaccination: Sutton’s law applied to prevention.  Infect Control Hosp Epidemiol 2000;21692- 699PubMedGoogle ScholarCrossref
12.
Govaert  TMEThijs  CTMasurel  NSprenger  MJDinant  GJKnottnerus  JA The efficacy of influenza vaccination in the elderly individuals: a randomized double-blind placebo-controlled trial.  JAMA 1994;2721661- 1665PubMedGoogle ScholarCrossref
13.
Fedson  DS Adult immunization: summary of the National Vaccine Advisory Committee Report.  JAMA 1994;2721133- 1137PubMedGoogle ScholarCrossref
14.
Nichol  KL Ten-year durability and success of an organized program to increase influenza an pneumococcal vaccination rates among high-risk adults.  Am J Med 1998;105385- 392PubMedGoogle ScholarCrossref
15.
Centers for Disease Control and Prevention (CDC), Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep 1997;46 ((RR-9)) 1- 25Google Scholar
16.
Public Health Service, Healthy People 2000: National Health Promotion and Disease Prevention Objectives: Healthy People 2000 Review 1998-1999.  Washington, DC US Dept of Health and Human Services, Public Health Services1999;DHHS publication (PHS)99-1256
17.
US Department of Health and Human Services, Healthy People 2010. Conference ed. Washington, DC US Dept of Health and Human Services;2000;
18.
Centers for Disease Control and Prevention (CDC), National Health Interview Survey. Available at: http://www.cdc.gov/nchs/about/major/nhis/quest_data_related_doc.htm. Accessed March 10, 2004
19.
National Center for Health Statistics, Vital and Health Statistics: Design and Estimation for National Health Interview Survey, 1985-1994.  Hyattsville, Md National Center for Health Statistics1989;DHHS publication 89-1384
20.
National Center for Health Statistics, Vital and Health Statistics: Design and Estimation for National Health Interview Survey 1995-2004.  Hyattsville, Md National Center for Health Statistics2000;DHHS publication 2000-1330
21.
U.S. Census Bureau, Current poverty data. Available at: http://www.census.gov/hhes/www/poverty/poverty.html. Accessed May 8, 2004
22.
Shah  BBarnwell  BBieier  G SUDAAN User’s Manual, Release 7.5.  Research Triangle Park, NC Research Triangle Institute1997;
23.
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics.  National Health Interview Survey, 1989-1991 [data sets on CD ROM]. Series 10. Atlanta, Ga Centers for Disease Control and Prevention1993;Google Scholar
24.
 Influenza and pneumococcal vaccination levels among persons aged ≥65 years–United States, 1973-1993.  MMWR Morb Mortal Wkly Rep 1995;44506- 507, 513-515PubMedGoogle Scholar
25.
Centers for Disease Control and Prevention (CDC), Estimated influenza vaccination coverage among adults and children—United States, September 1, 2004–January 31, 2005.  MMWR Morb Mortal Wkly Rep 2005;54304- 307PubMedGoogle Scholar
26.
Singleton  JAPoel  AJLu  PJNichol  KLIwane  MK Where adults reported receiving influenza vaccination in the United States  Am J Infect Control In pressGoogle Scholar
27.
Davis  MMMcMahon  SRSantoli  JMSchwartz  BClark  SJ A national survey of physician practices regarding influenza vaccine.  J Gen Intern Med 2002;17670- 676PubMedGoogle ScholarCrossref
28.
Casalino  LGillies  RRShortell  SM  et al.  External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases.  JAMA 2003;289434- 441PubMedGoogle ScholarCrossref
29.
Shefer  ABriss  PRodewald  L  et al.  Improving immunization coverage rates: an evidence-based review of the literature.  Epidemiol Rev 1999;2196- 142PubMedGoogle ScholarCrossref
30.
Stone  EGMorton  SCHulscher  ME  et al.  Interventions that increase use of adult immunization and cancer screening services: a meta-analysis.  Ann Intern Med 2002;136641- 651PubMedGoogle ScholarCrossref
31.
Coleman  MSFontanesi  JMeltzer  MI  et al.  Estimating medical practice expenses from administering adult influenza vaccinations.  Vaccine 2005;23915- 923Google ScholarCrossref
32.
Centers for Medicare and Medicaid Services, Medicare Preventive Services: Flu Pneus. Available at: http://www.cms.hhs.gov/preventiveservices/2l.pdf. Accessed January 20, 2005
33.
Centers for Medicare and Medicaid Services, Medicare Preventive Service: Influenza/Pneumococcal Campaign. Available at: http://www.cms.hhs.gov/preventiveservices/2.asp. Accessed January 20, 2005
34.
Nichol  KLMacDonald  RHauge  M Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.  J Gen Intern Med 1996;11673- 677PubMedGoogle ScholarCrossref
35.
 Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations–United States, 1996.  MMWR Morb Mortal Wkly Rep 1999;48886- 890PubMedGoogle Scholar
36.
Zimmerman  RKSantibanez  TAJanosky  JE  et al.  What affects influenza vaccination rates among older patients? an analysis from inner-city, suburban, rural, and Veterans Affairs practices.  Am J Med 2003;11431- 38PubMedGoogle ScholarCrossref
37.
Nicoleau  ANicoleau  CABalzora  JDOboh  ASiddiqui  NRosenberg  C Elderly African-Americans and the influenza vaccine: the impact of the primary care physician.  J Am Med Dir Assoc 2001;256- 59PubMedGoogle ScholarCrossref
38.
Horby  PWWilliams  ABurgess  MAWang  H Prevalence and determinants of influenza vaccination in Australians aged 40 years and over: a national survey.  Aust N Z J Public Health 2005;2935- 37PubMedGoogle ScholarCrossref
39.
Nunes  BContreiras  TFalcao  JM Influenza vaccination: coverage of Portuguese population from 1998/1999 to 2002/2003 [in Portuguese] [published correction appears in Rev Port Pneumol. 2004;10:451-452].  Rev Port Pneumol 2004;10115- 123PubMedGoogle Scholar
40.
Jin  YCarriere  KCPredy  GJohnson  DHMarrie  TJ The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta.  Can J Public Health 2003;94341- 345PubMedGoogle Scholar
41.
Luthi  JCMean  FAmmon  CBurnand  B Evaluation of a population-based prevention program against influenza among Swiss elderly people.  Swiss Med Wkly 2002;132592- 597Google Scholar
42.
Singleton  JAGreby  SMWooten  KGWalker  FJStrikas  R Influenza, pneumococcal, and tetanus toxoid vaccination of adults–United States, 1993-7.  MMWR CDC Surveill Summ 2000;4939- 62PubMedGoogle Scholar
43.
Singleton  JALu  PJ Influenza vaccination levels in the United States, 1998 [abstract].  Abstracts of the 35th National Immunization Conference. Atlanta, Ga;2001;
44.
 Race-specific differences in influenza vaccination levels among Medicare beneficiaries–United States, 1993.  MMWR Morb Mortal Wkly Rep 1995;4424- 27, 33PubMedGoogle Scholar
45.
Bach  PBPham  HHSchrag  DTate  RCHargraves  JL Primary care physicians who treat blacks and whites.  N Engl J Med 2004;351575- 584PubMedGoogle ScholarCrossref
46.
Schneider  ECZaslavsky  AMEpstein  AM Racial disparities in the quality of care for enrollees in Medicare managed care.  JAMA 2002;2871288- 1294PubMedGoogle ScholarCrossref
47.
Gemson  DHElinson  JMesseri  P Differences in physician prevention practice patterns for white and minority patients.  J Community Health 1988;1353- 64PubMedGoogle ScholarCrossref
48.
 Influenza and pneumococcal vaccination levels among persons aged ≥65 years–United States, 1999.  MMWR Morb Mortal Wkly Rep 2001;50532- 537PubMedGoogle Scholar
49.
Petersen  RLSaag  KWallace  RBDoebbeling  BN Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study.  Med Care 1999;37502- 509PubMedGoogle ScholarCrossref
50.
Lave  JRIves  DGTraven  NDKuller  LH Participation in health promotion programs by the rural elderly.  Am J Prev Med 1995;1146- 53PubMedGoogle Scholar
51.
Mac Donald  RBaken  LNelson  ANichol  KL Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.  Am J Prev Med 1999;16173- 177PubMedGoogle ScholarCrossref
52.
Nichol  KLKorn  JEBaum  P Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire.  Am J Prev Med 1991;7199- 203PubMedGoogle Scholar
53.
Hutchison  BG Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost.  Can J Public Health 1989;80271- 275PubMedGoogle Scholar
54.
 Centers for Disease Control and Prevention (CDC).  Interim estimates of populations targeted for influenza vaccination from 2003 National Health Interview Survey data and estimates for 2004 based on influenza vaccine shortage priority groups. Available at: http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf. Accessed November 10, 2004Google Scholar
55.
Centers for Disease Control and Prevention (CDC), Public health and aging: influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years—United States, 2002.  MMWR Morb Mortal Wkly Rep 2003;52987- 992PubMedGoogle Scholar
×